Room: MH2
Reporter: HATEGEKIMANA JOSELYNE AND UWIMANA CLEMENTINE

Teto George presented about "C Terminal p7 Gag polymorphism and protease drug resistance mutations profile in HIV-1 infected patients failing protease inhibitors treatment ". He showed that there are patients failing protease inhibition combination therapy without any drug resistance mutations in protease gene.

Matume Daphney made a presentation on "Prevalence and diversity of HIV drug resistance mutations in patients entering treatment programme in northern south Africa". The presentation showed that South Africa had the world's largest antiretroviral therapy programme. From her research of a sample of 338 individuals on antiretroviral therapy, 36 had mutations. This mutations also emerge in women who receive single dose for theprevention of mother to child transmission.

Dr Edmond TCHIAKPE presentee par "Forte precedence De La resistance transmise du VIH-1 chef les patients nouvellement antiretroviral au Benin". L' objective etait " Documenter les profils de mutations de resistance associees aux ARV chef les patients nails De treatement antiretroviral. Le resultat de cet etude est que Le Taux de resistance transimise au Benin est 10, 90% similaire au Togo, Taux eleve est 9,9% au Mali et Taux moderé est 7,9% au Mali.